Thursday, June 17, 2021

blood clots

EMA official says remarks on AstraZeneca jab ‘not interpreted correctly’

Marco Cavaleri says the vaccine 'maintains a favourable benefit risk profile in all ages but particularly in the elderly above 60'.

EMA official suggests ditching AstraZeneca jab

But the EMA's head of vaccine strategy acknowledges that incidents of blood clots are very rare, and that the vaccination programme in the UK is going well.

Chile limits use of AstraZeneca after blood clot case

The shot will be administered only to people aged 45 and over, as a 'preventative and proactive measure' pending further investigation.

First case of AstraZeneca jab blood clotting recorded in South Korea

A group of German scientists claim to have found the cause of the rare blood clots.

Scientists may have discovered why certain Covid jabs can cause blood clots

Scientists and drug regulators have been searching for an explanation for what is causing the rare but potentially deadly side effect.

British woman dies in Cyprus after AstraZeneca jab

Cyprus is also investigating four other cases of 'mild' blood clotting, three after an AstraZeneca jab and one after a Pfizer shot.

Austria to phase out AstraZeneca jabs

Its health minister says the jab is safe but cites bad press and delivery problems.

‘Minuscule’ clotting risk after AstraZeneca Covid jabs, says India

India's health ministry says the rate of such events are 0.61 per million doses, much lower than those reported in the UK.

Covid-19, the catch-22 numbers game

How we approach it will depend on which numbers we choose to zoom in on.

Norway drops AstraZeneca, offers J&J to volunteers only

From the approximately 135,000 injections of AstraZeneca's vaccine administered in Norway up until mid-March, eight cases of severe thrombosis were reported, four of them fatal.

Brazil states suspend AstraZeneca jabs for pregnant women

The suspension will remain in place until the health ministry establishes the cause of death of a woman in Rio de Janeiro who received the vaccine.

Canadian province pauses first dose rollout of AstraZeneca jabs

Health authorities cite new data showing increased risks of blood clotting as well as a possible supply shortage.

Other News